Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA drug recalls in 2016

Every FDA drug recall initiated in 2016, newest first, with its risk class, status and the reason the FDA recorded. Use the cause and risk filters to narrow the year down.

1,199 recalls, newest first.

Risk Class IClass IIClass III
Status OngoingCompletedTerminated
Year 20262025202420232022 2016 All years
Cause Sterility / contaminationNitrosamine impurityChemical / undeclaredParticulate / foreign matterLabeling / mix-upcGMP deviationMicrobial contamination All causes
Class I · High risk

Night Man

Marketed Without An Approved NDA/ANDA

Terminated Unapproved drug R Thomas Marketing, LLC D-0903-2016
Class I · High risk

Mojo Risen

Marketed Without An Approved NDA/ANDA

Terminated Unapproved drug R Thomas Marketing, LLC D-0902-2016
Class I · High risk

Man King

Marketed Without An Approved NDA/ANDA

Terminated Unapproved drug R Thomas Marketing, LLC D-0901-2016
Class I · High risk

Hard Ten Days

Marketed Without An Approved NDA/ANDA

Terminated Unapproved drug R Thomas Marketing, LLC D-0900-2016
Class I · High risk

Plant Vigra

Marketed Without An Approved NDA/ANDA

Terminated Unapproved drug R Thomas Marketing, LLC D-0899-2016
Class I · High risk

Germany Niubian

Marketed Without An Approved NDA/ANDA

Terminated Unapproved drug R Thomas Marketing, LLC D-0897-2016
Class I · High risk

Black Storm

Marketed Without An Approved NDA/ANDA

Terminated Unapproved drug R Thomas Marketing, LLC D-0896-2016
Class I · High risk

Black Ant King

Marketed Without An Approved NDA/ANDA

Terminated Unapproved drug R Thomas Marketing, LLC D-0895-2016
Class I · High risk

Bull's Genital

Marketed Without An Approved NDA/ANDA

Terminated Unapproved drug R Thomas Marketing, LLC D-0891-2016
Class I · High risk

Bull

Marketed Without An Approved NDA/ANDA

Terminated Unapproved drug R Thomas Marketing, LLC D-0890-2016
Class I · High risk

Weekend Prince

Marketed Without An Approved NDA/ANDA

Terminated Unapproved drug R Thomas Marketing, LLC D-0888-2016
Class I · High risk

Stree Overlord

Marketed Without An Approved NDA/ANDA

Terminated Unapproved drug R Thomas Marketing, LLC D-0887-2016
Class I · High risk

Real Skill

Marketed Without An Approved NDA/ANDA

Terminated Unapproved drug R Thomas Marketing, LLC D-0886-2016
Class I · High risk

Herb Viagra

Marketed Without An Approved NDA/ANDA

Terminated Unapproved drug R Thomas Marketing, LLC D-0885-2016
Class I · High risk

Black Ant

Marketed Without An Approved NDA/ANDA

Terminated Unapproved drug R Thomas Marketing, LLC D-0884-2016
Class II · Moderate risk

Guaifenesin DM Cherry liquid

Defective Delivery System: Firm recalled Guaifenesin liquid and Guaifenesin DM liquid due incorrect dose markings on the dosing cups.

Terminated Packaging defect Perrigo Company PLC NDC 49348-828-34 D-0587-2016
Class II · Moderate risk

Guaifenesin Grape liquid 100 mg/5 mL

Defective Delivery System: Firm recalled Guaifenesin liquid and Guaifenesin DM liquid due incorrect dose markings on the dosing cups.

Terminated Packaging defect Perrigo Company PLC NDC 37808-288-26 D-0586-2016

Recalls by year